$WTER
ALKALINE WATER Co INC

2022 Form 10-K Financial Statement

#000106299322016353 Filed on July 14, 2022

View on sec.gov

Income Statement

Concept 2022 2021 Q1 2021
Revenue $60.60M $10.91M $40.07M
YoY Change 51.23% -9.73% -2.6%
Cost Of Revenue $45.38M $8.941M $29.62M
YoY Change 53.19% 23.32% 21.9%
Gross Profit $15.22M $1.973M $16.45M
YoY Change -7.47% -59.23% -2.34%
Gross Profit Margin 25.12% 18.08% 41.05%
Selling, General & Admin $54.21M $6.219M $32.27M
YoY Change 67.99% -26.05% 6.82%
% of Gross Profit 356.19% 315.14% 196.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $801.4K $307.8K $997.8K
YoY Change -19.68% 9.93% -1.21%
% of Gross Profit 5.27% 15.6% 6.07%
Operating Expenses $54.22M $6.522M $32.28M
YoY Change 67.95% -24.94% 3.4%
Operating Profit -$39.00M -$4.549M -$15.83M
YoY Change 146.29% 18.16% 10.11%
Interest Expense -$917.0K -$117.4K -$575.6K
YoY Change 59.31% -9.66% 27.91%
% of Operating Profit
Other Income/Expense, Net -$586.5K
YoY Change
Pretax Income -$39.58M -$4.667M -$16.41M
YoY Change 141.23% 17.25% 10.65%
Income Tax
% Of Pretax Income
Net Earnings -$39.58M -$4.667M -$16.41M
YoY Change 141.23% 17.25% 10.65%
Net Earnings / Revenue -65.32% -42.76% -40.95%
Basic Earnings Per Share -$0.40 -$0.24
Diluted Earnings Per Share -$0.40 -$58.96K -$0.24
COMMON SHARES
Basic Shares Outstanding 6.608M shares
Diluted Shares Outstanding 6.608M shares

Balance Sheet

Concept 2022 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.531M $9.131M $9.131M
YoY Change -83.23% 100.24% 100.24%
Cash & Equivalents $9.131M
Short-Term Investments
Other Short-Term Assets $3.116M $1.274M $1.274M
YoY Change 144.48% -28.8% -28.8%
Inventory $8.584M $4.408M $4.408M
Prepaid Expenses
Receivables $7.927M $8.458M $8.458M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.16M $23.27M $23.27M
YoY Change -9.08% 64.08% 64.11%
LONG-TERM ASSETS
Property, Plant & Equipment $1.343M $1.010M $1.279M
YoY Change 4.99% -28.86% -9.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.343M $1.279M $1.279M
YoY Change 4.99% -10.07% -10.53%
TOTAL ASSETS
Total Short-Term Assets $21.16M $23.27M $23.27M
Total Long-Term Assets $1.343M $1.279M $1.279M
Total Assets $22.50M $24.55M $24.55M
YoY Change -8.35% 57.32% 57.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.44M $7.055M $7.055M
YoY Change 48.0% 30.5% 30.41%
Accrued Expenses $2.211M $1.306M $1.536M
YoY Change 43.99% 10.08% 19.05%
Deferred Revenue
YoY Change
Short-Term Debt $9.268M $4.324M $4.324M
YoY Change 114.31% -40.68% -40.68%
Long-Term Debt Due $0.00 $328.6K $328.6K
YoY Change -100.0%
Total Short-Term Liabilities $21.92M $13.24M $13.24M
YoY Change 65.51% -5.29% -5.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $178.8K $292.6K $292.6K
YoY Change -38.91%
Total Long-Term Liabilities $178.8K $292.6K $292.6K
YoY Change -38.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.92M $13.24M $13.24M
Total Long-Term Liabilities $178.8K $292.6K $292.6K
Total Liabilities $22.10M $13.54M $13.54M
YoY Change 63.26% -3.2% -3.17%
SHAREHOLDERS EQUITY
Retained Earnings -$69.93M
YoY Change 30.66%
Common Stock $87.46K
YoY Change 91.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $401.1K $11.01M $11.01M
YoY Change
Total Liabilities & Shareholders Equity $22.50M $24.55M $24.55M
YoY Change -8.35% 57.32% 57.27%

Cashflow Statement

Concept 2022 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$39.58M -$4.667M -$16.41M
YoY Change 141.23% 17.25% 10.65%
Depreciation, Depletion And Amortization $801.4K $307.8K $997.8K
YoY Change -19.68% 9.93% -1.21%
Cash From Operating Activities -$31.82M -$4.680M -$14.28M
YoY Change 122.82% -1.68% 4.69%
INVESTING ACTIVITIES
Capital Expenditures -$992.0K -$435.4K -$585.4K
YoY Change 69.46% 74.16% 19.47%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$992.0K -$435.4K -$585.4K
YoY Change 69.46% 74.16% 19.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.90M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.21M 12.52M 19.43M
YoY Change 29.72% 131.94% 153.72%
NET CHANGE
Cash From Operating Activities -31.82M -4.680M -14.28M
Cash From Investing Activities -992.0K -435.4K -585.4K
Cash From Financing Activities 25.21M 12.52M 19.43M
Net Change In Cash -7.600M 7.409M 4.569M
YoY Change -266.33% 1799.82% -170.62%
FREE CASH FLOW
Cash From Operating Activities -$31.82M -$4.680M -$14.28M
Capital Expenditures -$992.0K -$435.4K -$585.4K
Free Cash Flow -$30.83M -$4.245M -$13.69M
YoY Change 125.1% -5.88% 4.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2022 wter Allocated Share Based Compensation Expense Year Three
AllocatedShareBasedCompensationExpenseYearThree
3227030 usd
CY2022 wter Allocated Share Based Compensation Expense Year Four
AllocatedShareBasedCompensationExpenseYearFour
185586 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11013986 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
2227031 usd
CY2022 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
1524750 usd
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0367049
CY2022 wter Noncash Interest Expense
NoncashInterestExpense
24468 usd
CY2021Q1 wter Ppp Loan Payable Current Portion
PppLoanPayableCurrentPortion
328570 usd
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022 dei Auditor Name
AuditorName
Prager Metis CPAs, LLC
CY2022 dei Auditor Location
AuditorLocation
Basking Ridge, NJ
CY2022 dei Auditor Firm
AuditorFirmId
273
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
70000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
778966 usd
CY2021 wter Increase Decrease In Issuance Of Common Shares To Settle Stock Payable
IncreaseDecreaseInIssuanceOfCommonSharesToSettleStockPayable
1000000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4572567 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.84
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y1M6D
CY2021Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
4757381 shares
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></span></span></p> <p style="text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></span></p> </div>
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1790000 shares
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
239000 shares
CY2021Q3 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
1.25
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1100000 usd
CY2020 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
3725465 usd
CY2019 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
1591555 usd
CY2022 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>The Company records all property and equipment at cost less accumulated depreciation. Improvements are capitalized while repairs and maintenance costs are expensed as incurred. Depreciation is calculated using the straight-line (half-life convention) method over the estimated useful life of the assets or the lease term, whichever is shorter. </span></span><span style="line-height: 107%; color: black;">The Company evaluated its property and equipment for impairment and concluded for the year ended March 31, 2022, there was no impairment.</span></span></span></p> </div>
CY2021Q4 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
666667 shares
CY2021 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
1697537 usd
CY2021Q4 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
1.25
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span style="text-decoration: underline;">Concentration Risks</span></span></span></p> <p style="text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;">We have 3 major customers that together account for 43% (19%, 12% and 12%, respectively) of accounts receivable at March 31, 2022, and 2 customers that together account for 34% (19% and 15%, respectively) of the total revenues earned for the year ended March 31, 2022.The Company has 3 vendors that accounted for 47% (24%, 12%, and 11% respectively) of purchases for the year ended March 31, 2022.</span></span></p> </div>
CY2019Q2 us-gaap Lease Deposit Liability
LeaseDepositLiability
185510 usd
CY2022Q1 wter Retained Earnings Accumulated Deficit Since Inception
RetainedEarningsAccumulatedDeficitSinceInception
-109295337 usd
CY2022 us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
Under the terms of the Credit Agreement, SCM has agreed to make cash advances to our company in an aggregate principal at any one time outstanding not to exceed the lesser of (i) $10 million (the "Revolving Loan Commitment Amount") and (ii) the Borrowing Base (defined to mean, as of any date of determination, 85% of net eligible billed receivables plus 65% of eligible unbilled receivables, minus certain reserves).
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7043870 usd
CY2022Q1 wter Additional Aggregate Cash Payments
AdditionalAggregateCashPayments
1000000 usd
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
833334 usd
CY2022Q1 wter Aggregate Cash Payments For Fiscal Year Three
AggregateCashPaymentsForFiscalYearThree
250000 usd
CY2022Q1 wter Aggregate Cash Payments For Fiscal Year Two
AggregateCashPaymentsForFiscalYearTwo
250000 usd
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2033900 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
165333 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
129000 shares
CY2021 wter Class Of Warrant Or Right Forfeitures And Expirations In Period
ClassOfWarrantOrRightForfeituresAndExpirationsInPeriod
1709424 shares
CY2022 wter Class Of Warrant Or Right Forfeitures And Expirations In Period
ClassOfWarrantOrRightForfeituresAndExpirationsInPeriod
0 shares
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
213129 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1621199 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Selling Expense
SellingExpense
13850620 usd
CY2021 us-gaap Selling Expense
SellingExpense
7432077 usd
CY2019Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
165699 usd
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.11
CY2018Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.29
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2019 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
3900000 shares
CY2019 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.5
CY2018Q2 wter Units Issued During Period
UnitsIssuedDuringPeriod
5131665 shares
CY2018Q2 wter Units Issued During Period Per Unit Amount
UnitsIssuedDuringPeriodPerUnitAmount
0.75
CY2018Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3848749 usd
CY2018Q2 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.9
CY2022 wter Finders Fees
FindersFees
123572 usd
CY2022Q1 wter Warrants Issued
WarrantsIssued
49428 shares
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7043870 usd
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4324412 usd
CY2022Q1 wter Ppp Loan Payable Current Portion
PppLoanPayableCurrentPortion
0 usd
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110571812 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110571812 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87465178 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87465178 shares
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
161100 shares
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116000 shares
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
188081 shares
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108181 usd
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
48158 shares
CY2022 wter Increase Decrease In Issuance Of Common Shares To Settle Stock Payable
IncreaseDecreaseInIssuanceOfCommonSharesToSettleStockPayable
0 usd
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61480 usd
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1950000 usd
CY2020Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
258899 usd
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
172521 usd
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16802 usd
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4375000 usd
CY2020Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
91666 usd
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
977777 usd
CY2020Q2 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
287666 shares
CY2020Q2 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.9
CY2020Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
81400 shares
CY2020Q3 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
2.9
CY2020Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
7999 shares
CY2020Q3 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
2.9
CY2020Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
8750000 shares
CY2020Q3 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.5
CY2020Q4 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
166000 shares
CY2020Q4 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.55
CY2021Q1 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
2000000 shares
CY2021Q1 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.55
CY2021Q1 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
1777777 shares
CY2021Q1 wter Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.55
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
65000000 usd

Files In Submission

Name View Source Status
0001062993-22-016353-index-headers.html Edgar Link pending
0001062993-22-016353-index.html Edgar Link pending
0001062993-22-016353.txt Edgar Link pending
0001062993-22-016353-xbrl.zip Edgar Link pending
exhibit14-1.htm Edgar Link pending
exhibit14-1x001.jpg Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wter-20220331.xsd Edgar Link pending
wter-20220331_cal.xml Edgar Link unprocessable
wter-20220331_def.xml Edgar Link unprocessable
wter-20220331_lab.xml Edgar Link unprocessable
wter-20220331_pre.xml Edgar Link unprocessable